Knowde Enhanced TDS
Identification & Functionality
- Polymer Name
- Technologies
Features & Benefits
- Materials Features
- Product Highlights
The MARFRAN.MED® compounds have been tested in the experimental phase both in the normal forms of machining (extrusion, injection molding, blow molding) both in the most demanding processes and in micro-extrusion / co-extrusion and micro-molding. The high degree of workability allows to obtain semi-finished products characterized by:
- High flexibility, softness to the touch.
- Absence of PVC, silicone and latex throughout the production chain.
- High transparency and medical coloring.
- Reworkable waste.
- Possibility of sterilization with gamma rays, Eto and steam.
- Optical control in-line sorting system for each granule.
- Low friction surfaces. • High precision and dimensional stability.
- Stable working and process conditions.
- High performance in the 2K molding process.
- Short drying process, guarantee of rheological homogeneity of the batch.
- Ease of assembly, reduction of cooling times.
- No external migration phenomenon for oil-free compounds.
- Resistance to usual fluids used in the medical and pharmaceutical sector.
- Adherence to polyolefins with co-extrusion and molding processes, special qualities for adhesion a PC, ABS, PMMA, SAN, ASA, PA6. No release of toxic gasses during processing.
- Limited thermal degradation (no black spots, no yellowing) in the normal range of process temperatures (160 ° C-220 ° C). No moisture absorption over time.
- Wide range of operating temperatures (-50 ° C to 125 ° C depending on hardness).
The range of products finds application in the production of countless semi-finished products dedicated to the medical and pharmaceutical industry.
MARFRAN.MED® is produced in compliance with ISO 9001 and ISO 13485 (standard for production of medical devices). Each compound is certified according to ISO 10993 (line
guide for the safety assessment of biocompatibility of medical devices for the body) and the USP Class VI standard, American Pharmacopeia for requirements of chemical quality, purity, strength and consistency. We have passed the highest Class VI and met all the requirements of the test as our compound has a very low toxicity level.
Our compounds have also been tested according to the European Pharmacopeia Ed. 8.1 2014. La European Pharmacopeia and the requirements it requires are legally binding on States Members of the European Pharmacopeia Convention and of the European Union. All tests performed on our compounds they certify a complete compliance with the required values. Our product passes the tests for acidity and alkalinity, absorption, sulphated ash and extensibility of materials such as aluminum, chromium, titanium, vanadium, zinc and heavy metals.
MARFRAN.MED® compounds are mechanically tested before and after the main processes of steam sterilization (autoclave), gamma and Eto. The differences between the values obtained allow to confirm that the various sterilization processes do not significantly affect the size of the mechanical characteristics of the compound.- Product Highlights
The MARFRAN.MED® compounds have been tested in the experimental phase both in the normal forms of machining (extrusion, injection molding, blow molding) both in the most demanding processes and in micro-extrusion / co-extrusion and micro-molding. The high degree of workability allows to obtain semi-finished products characterized by:
- High flexibility, softness to the touch.
- Absence of PVC, silicone and latex throughout the production chain.
- High transparency and medical coloring.
- Reworkable waste.
- Possibility of sterilization with gamma rays, Eto and steam.
- Optical control in-line sorting system for each granule.
- Low friction surfaces. • High precision and dimensional stability.
- Stable working and process conditions.
- High performance in the 2K molding process.
- Short drying process, guarantee of rheological homogeneity of the batch.
- Ease of assembly, reduction of cooling times.
- No external migration phenomenon for oil-free compounds.
- Resistance to usual fluids used in the medical and pharmaceutical sector.
- Adherence to polyolefins with co-extrusion and molding processes, special qualities for adhesion a PC, ABS, PMMA, SAN, ASA, PA6. No release of toxic gasses during processing.
- Limited thermal degradation (no black spots, no yellowing) in the normal range of process temperatures (160 ° C-220 ° C). No moisture absorption over time.
- Wide range of operating temperatures (-50 ° C to 125 ° C depending on hardness).
Applications & Uses
- Applications
- Plastics & Elastomers End Uses
- Plastics & Elastomers Processing Methods
- Applications
It produce colored and TPE compounds transparent for molding applications ad injection, extrusion and blow molding. Between applications suitable for MARFRAN.MED®: drip chambers and their closures, perforated caps, connectors, dental bites, droppers, wheels, blood bags, catheters, tubes and peristaltic pumps, containers for ophthalmic preparations, containers for supplements, bags for food, containers, and connectors for the sector parenteral nutrition E .
The range of products finds application in the production of countless semi-finished products dedicated to the medical and pharmaceutical industry.
- Applications
- Extrusion & microextr
- Injection molding
Properties
- Appearance
- Translucent
- Typical Properties
| Value | Units | Test Method / Conditions | |
| Hardness | 20 - 95 | Shore A | — |
| Density | 0.89 | g/cm³ | — |
| Tensile Strength | 3.0 - 13.0 | MPa | — |
| Elongation at Break | 800 - 700 | % | — |
| Tear Strength | 9.0 - 44.0 | N/m | — |
Regulatory & Compliance
- Certifications & Compliance